PomegraSanté, a New York AI and fintech platform for wine and liquor stores, closed a $15M Series A led by FINTOP, bringing its total funding to about $22.6M.
- Santé raised a $15M Series A led by FINTOP on October 6, 2026, six months after a $7.6M seed round.
- The platform runs nearly 1,000 stores and processes more than $2B in annual gross merchandise value.
- Valuation was not disclosed. Total funding stands at roughly $22.6M.
Lead
Santé, a New York company building an AI operating system for independent wine and spirits retailers, announced a $15M Series A on October 6, 2026. FINTOP led the round. Existing investors Bonfire Ventures, Operator Collective, Y Combinator and Veridical Ventures also participated. The company did not disclose a valuation.
The raise comes six months after a $7.6M seed round. Santé says it has grown 500% over that period and now powers nearly 1,000 storefronts, with annual GMV above $2B. CEO and founder Darren Fike runs the company.
What Does Santé Actually Sell?
Santé sells a point-of-sale system for liquor stores that bundles in-store checkout, e-commerce, third-party delivery integrations, marketing and subscriptions into one product. It targets the roughly 34,000 independent liquor retailers in the US, a segment that has relied on legacy software built before online ordering and delivery apps became standard.
On top of that base sits a set of AI agents. A merchandising agent targets slow inventory, and the company cites a figure that about 25% of stock takes more than 12 months to turn a profit. A receiving agent scans supplier invoices and updates inventory automatically. A marketing agent handles customer segmentation and campaigns, and a catalog tool generates SEO-optimized product descriptions for online listings.
Delivery integrations cover DoorDash, Uber Eats, GrubHub and Instacart. Liquor-specific features include bottle and keg tracking, vintage management and case discounts. An employee scheduling agent based on sales patterns is in rollout, and accounts payable automation is in development.
How Does Santé Make Money?
Santé earns revenue from subscription fees plus payment processing, so income rises with the volume a store runs through the system. That is the standard vertical SaaS plus embedded fintech model, and it explains FINTOP's involvement: the investor focuses on fintech-enabled software. FINTOP's Brittani Roberts credited the team's execution and its "intuitive AI workflows with embedded fintech" for helping retailers expand profit margins.
The $2B GMV figure matters more than the store count. At that volume, even a small processing take rate produces meaningful revenue, though Santé has not disclosed revenue, margins or take rate. The 500% growth claim also lacks a stated base, so it is hard to judge against a seed-stage company's starting point.
Why Did Investors Fund a Liquor Store POS?
Investors backed Santé because liquor retail combines heavy regulation, very high SKU counts and thin margins, which make manual back-office work expensive. Stores deal with compliance rules, large product catalogs and paper invoices. Fike has said store owners care about "saving time, reducing labor costs, and moving inventory," which frames the pitch as labor and inventory efficiency rather than novelty AI.
The round also fits a broader pattern of vertical software companies adding AI agents to workflows that were previously handled by clerks and spreadsheets. The claim is testable: if invoice scanning and automated ordering cut hours per week and reduce dead stock, retention should show it. Santé has not published retention or customer-level savings data.
What Competition Does Santé Face?
Santé competes with incumbent liquor POS vendors and general retail systems that also sell payments. Incumbents hold the installed base and switching costs, since replacing a POS means retraining staff and migrating inventory data across tens of thousands of SKUs. Santé's argument is that its all-in-one design, built around liquor-specific workflows, beats bolt-on AI added to older systems.
The market is sizable. The company puts estimated 2026 US liquor retail sales at about $87.2B, and its roughly 1,000 stores represent a small share of the independent universe. Growth from here depends on winning customers away from entrenched vendors rather than on greenfield adoption.
What Comes Next for Santé?
Santé plans to expand its engineering and go-to-market teams and to ship more agents, including scheduling and accounts payable. The company has not disclosed headcount or a revenue target.
The next test is whether growth holds without the lift of a first wave of early adopters. Seed to Series A in six months is fast, and a $15M round sets a higher bar for the next one. Metrics worth watching include store count, GMV per store and how much of that volume flows through Santé's own payments rails.
Outlook
Santé enters its Series A phase with about 1,000 stores, $2B in GMV and $22.6M raised in total, but no disclosed valuation, revenue or retention figures. The product thesis is clear: one system for checkout, online sales and back-office tasks, with AI agents doing the repetitive work. Execution will be judged on whether independent retailers stay once the novelty fades and whether payments revenue scales with GMV.